Discover
CNTB
Connect Biopharma Holdings Limited
2.01
2 x 1.50
2 x 2.71
bid
ask
+
0.10
5.24%
2 @ 06:23 AM
2.04 +0.03 (1.49%)
| Ytd | -28.72% | |
| 1y | 14.20% |
1.89
day range
2.10
1.23
52 week range
3.82
| Open | 1.91 | Prev Close | 1.91 | Low | 1.89 | High | 2.10 | Mkt Cap | 126.58M |
| Vol | 945.52K | Avg Vol | 648.40K | EPS | -1.19 | P/E | N/A | Forward P/E | -5.04 |
| Beta | -0.23 | Short Ratio | 1.93 | Inst. Own | 44.43% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 09-19 | 50-d Avg | 2.27 | 200-d Avg | 2.47 | 1yr Est | 7.00 |
| Income Statement | |||
| Total Revenue | 2.77M | ||
| Revenues (USD) | 2.77M | ||
| Gross Profit | 2.77M | ||
| Operating Expenses | 20.37M | ||
| Research and Development Expense | 16.27M | ||
| Selling, General and Administrative Expense | 4.10M | ||
| Operating Income | -17.60M | ||
| Income Tax Expense | 60.00K | ||
| Net Income | -17.28M | ||
| Net Income Common Stock | -17.28M | ||
| Net Income Common Stock (USD) | -17.28M | ||
| Consolidated Income | -17.28M | ||
| Earnings per Basic Share | -0.27 | ||
| Earnings per Basic Share (USD) | -0.27 | ||
| Earnings per Diluted Share | -0.27 | ||
| Earning Before Interest & Taxes (EBIT) | -17.22M | ||
| Earning Before Interest & Taxes (USD) | -17.22M | ||
| Weighted Average Shares | 62.88M | ||
| Weighted Average Shares Diluted | 62.88M | ||
| Balance Sheet | |||
| Cash and Equivalents | 27.02M | ||
| Cash and Equivalents (USD) | 27.02M | ||
| Investments | 4.47M | ||
| Investments Current | 4.47M | ||
| Trade and Non-Trade Receivables | 2.94M | ||
| Current Assets | 38.62M | ||
| Property, Plant & Equipment Net | 4.16M | ||
| Total Assets | 43.47M | ||
| Debt Current | 393.00K | ||
| Total Debt | 596.00K | ||
| Current Liabilities | 16.30M | ||
| Debt Non-Current | 203.00K | ||
| Total Liabilities | 16.61M | ||
| Accumulated Retained Earnings (Deficit) | -437.52M | ||
| Accumulated Other Comprehensive Income | -962.00K | ||
| Shareholders Equity | 26.86M | ||
| Shareholders Equity (USD) | 26.86M | ||
| Assets Non-Current | 4.85M | ||
| Total Debt (USD) | 596.00K | ||
| Goodwill and Intangible Assets | 42.00K | ||
| Liabilities Non-Current | 310.00K | ||
| Trade and Non-Trade Payables | 2.02M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 161.00K | ||
| Net Cash Flow from Financing | 1.33M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -19.02M | ||
| Issuance (Purchase) of Equity Shares | 2.85M | ||
| Net Cash Flow from Investing | -4.47M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -4.47M | ||
| Net Cash Flow from Operations | -15.92M | ||
| Effect of Exchange Rate Changes on Cash | 45.00K | ||
| Share Based Compensation | 1.26M | ||